Aarogyaline maintains exceptional access to human biospecimens through its diverse nationwide network of collection sites, encompassing university and community hospitals, private medical clinics, pathology labs, blood banks, and specialized sourcing partners. Continuously expanding this network is a key commitment to meeting the evolving needs of the Life Science community.
- Collection sites are meticulously chosen based on their proven track record of quality, robust infrastructure, and capacity to conduct specimen collection studies effectively.
- Rigorous monitoring of sites ensures adherence to study protocols, encompassing precise subject recruitment as per inclusion/exclusion criteria, strict confidentiality maintenance, de-identification of clinical data, and accurate collection, processing, storage, and shipment of biospecimens.
- Trained personnel at collection sites are equipped to execute specimen collection studies proficiently, with comprehensive training records maintained onsite.
- All study documentation is meticulously stored in regulatory folders at the collection sites for a minimum of 5 years, ensuring compliance and accessibility for reference.